BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

SCTX

No price yet

Announcements

Nothing here yet

Daily updates

  • Scribe Therapeutics reported nonclinical results for its CRISPR-based cardiovascular candidates STX-1150 and STX-1200. A single prototype dose of STX-1150 produced over 50% sustained LDL cholesterol reduction for two years in nonhuman primates without permanent DNA alteration. An STX-1200 surrogate achieved over 95% Apo(a) suppression and more than 80% liver LPA editing, with no observed off-target activity across more than 125 evaluated sites in human liver cells. Initial Phase 1 STX-1150 data are expected in H1 2027.Nov 19, 2026

FDA designations

Nothing here yet

News

  • Scribe Therapeutics presented new data advancing the potential of ultra-long-acting genetic medicines for cardiovascular disease at the American Heart Association Scientific Sessions 2026.Nov 18, 2026
  • Scribe Therapeutics presented updated data on its PCSK9-targeting epigenetic silencing and LPA-targeting gene editing programs at the American Heart Association Scientific Sessions 2026.Nov 5, 2026

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2024-2026 Bio Pharma Stock. All rights reserved. Policy